Condition: Ulcerative Colitis, Unspecified · Sponsor: University Hospital Schleswig-Holstein
Double-blind, randomised, placebo-controlled phase II / III trial evaluating efficacy and safety of two different doses (2 g/d or 3 g/d) of oral controlled-ileocolonic-release nicotinamide (CICR-NAM) compared to placebo in patients with ulcerative colitis (UC). The intended therapeutic use of CICR-NAM is to improve intestinal inflammation in adults with UC by topically increasing nicotinamide supply in the ileocolonic region and thus favourably influencing the composition of intestinal microbiota
This description comes directly from the study's public registry record.
Stefan Schreiber, Prof. Dr. Dr. hc. · +4943150022200 · s.schreiber@mucosa.de
Friso Muijsers · +4943150030751 · info@zks.uni-kiel.de
Always discuss trial participation with your own doctor first.
| Universitaetsklinikum Schleswig-Holstein AöR | Kiel, Schleswig-Holstein, Germany | Recruiting |
| Universitaetsklinikum Aachen AöR | Aachen, Germany | Not Yet Recruiting |
| Universitaetsklinikum Augsburg | Augsburg, Germany | Recruiting |
| Sozialstiftung Bamberg | Bamberg, Germany | Recruiting |
| Charite Universitaetsmedizin Berlin KöR | Berlin, Germany | Recruiting |
| Charite Universitaetsmedizin Berlin KöR | Berlin, Germany | Recruiting |
| DRK Kliniken Berlin | Berlin, Germany | Recruiting |
| Gesundheit Nord gGmbH Klinikverbund Bremen | Bremen, Germany | Recruiting |
| Evangelisches Krankenhaus Kalk gGmbH | Cologne, Germany | Recruiting |
| Medical Care Unit Dachau | Dachau, Germany | Withdrawn |
| Gastroenterologie am Herrengarten | Darmstadt, Germany | Recruiting |
| Gastroenterologische Schwerpunktpraxis Prof. Dr. Ludwig & Dr. med. Güthle | Dornstadt, Germany | Recruiting |
+ 14 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06488625